TGen develops quality-control test for detecting cancer in blood Posted Wednesday May 9, 2018 Rapid, non-invasive diagnosis assisted by TGen assay could be used to help detect many types of cancer
Casey Strale Foundation tops $150,000 in gifts to TGen Posted Tuesday April 17, 2018 Memory of teenage hockey player spurs research in rare ACC cancer
Colleen’s Dream funds TGen ovarian cancer clinical trial Posted Tuesday April 3, 2018 Scottsdale-based nonprofit grants $450,000 to Phoenix research institute, TGen
TGen launches new discovery platform to guard human health Posted Monday April 2, 2018 Clinical Microbiome Services Center enhances TGen’s genomic analyses
Fitness for the Cure radically expands options to support TGen Posted Monday March 26, 2018 Non-members welcome to participate April 29 at any of four Village Health Clubs in Phoenix, Chandler and Scottsdale
TGen-ASU study identifies molecular response of muscle to different types of exercise Posted Tuesday March 20, 2018 Hundreds of genes are affected; different types of exercises affect unique sets of genes
TGen tests ultrasound as way to enhance cancer drug delivery Posted Monday March 19, 2018 Sound waves drive drug therapies to cancer cells; minimize toxicity
Destroy Pancreatic Cancer dedicates $1 million for unique TGen-designed clinical trial Posted Monday March 12, 2018 Non-profit created by cancer survivors aims for better treatments at Atlanta’s Piedmont Cancer Institute
Wendy’s Puts the Freeze on Cancer with Jr. Frosty Posted Monday March 5, 2018 $1 donation for 5 free Jr. Frosty coupons adds dollars for TGen cancer research
TGen-led study finds potent anti-cancer drug effect in rare ovarian cancer Posted Thursday March 1, 2018 Ponatinib is effective against SCCOHT, a type of ovarian cancer that mostly strikes young women and girls as young as 14 months